# Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass

> **NCT00620945** · NA · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 87 (actual)

## Conditions studied

- Congenital Heart Surgery
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** Phenoxybenzamine

## Key facts

- **NCT ID:** NCT00620945
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 87 (ACTUAL)
- **Why stopped:** New protocol now being used for cardiopulmonary bypass
- **Last updated:** 2017-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620945, "Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00620945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*